Evaluation of the Effect of Injectable Platelet Rich Fibrin on Stability of Dental Implant for Narrow Ridges

Overview

the main aim of the study is to evaluate the secondary implant stability when using dental implants with injectable platelet rich fibrin accompanied by non-autogenous bone graft material in narrow ridge cases versus straightforward ridges , in clinical comparative study.

Full Title of Study: “Evaluation of Secondary Dental Implant Stability Utilized For Narrow Ridges With Injectable Platelet Rich Fibrin Versus Straightforward Cases”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2023

Detailed Description

the main aim of the study is to evaluate the secondary implant stability when using dental implants with injectable platelet rich fibrin accompanied by non-autogenous bone graft material in narrow ridge cases versus straightforward ridges , in clinical comparative study. Study design: Forty implants will be installed for this prospective clinical study, the implants will be equally divided into two groups. Group A (control group) in which the implants will be installed in a straightforward cases. Group B (study group) in which the implants will be installed by utilizing injectable PRF with non-autogenous bone graft material in narrow ridges. Preparation of Injectable Platelet Rich Fibrin for the narrow ridge cases is as following: Five ML of autologous blood to be collected from the forearm (median cubital vein cephalic vein basilic vein ) by needle gauge with a 5mL sterile syringe without anticoagulant. The entire blood is moved to a 5 milliliter plastic tube, directly centrifugated for 3 minutes at 700 rpm/min at room temperature. A liquid form ( Injectable PRF ) is then achieved on top of the tube just and the red corpuscles at the bottom. Subsequently, the Injectable PRF liquid form is collected from the tube by a sterile plastic syringe, Then it will be mixed with non-autogenous bone graft waiting for 4min, and applied in the area with narrow ridge( deficiency in the horizontal bone width ) . Follow up Twenty four weeks after surgery , The uncoverage surgery is done under L.A using a tissue paunch for installing the healing abutment ( gingival former ) , Then the secondary stability of implant (Osseointegration) is to be measured using the (Anycheck ) device , and comparing the 2 groups

Interventions

  • Procedure: study group
    • dental implant procedure under local anesthesia
  • Procedure: control group
    • dental implant procedure under local anesthesia

Arms, Groups and Cohorts

  • Experimental: study group
    • patients need dental implants with narrow alveolar ridge of less than 6 mm horizontal width . they will receive dental implants with I_PRF mixed with synthetic bone graft.
  • Experimental: control group
    • patients need dental implant with adequate horizontal bone with of more than 6 mm.

Clinical Trial Outcome Measures

Primary Measures

  • secondary implant stability
    • Time Frame: six months
    • measured by Anycheck device after osseointegration time

Participating in This Clinical Trial

Inclusion Criteria

1. Patients ≥ 18 years of age. 2. Absence of general medical contraindications for oral surgery procedures such as (Radiated jaws / uncontrolled Diabetic patient / uncontrolled hypertensive patient ). 3. Straightforward cases / narrow ridges (less than 6mm horizontal bone width) according to SAC classification ( advanced surgery ) cases. 4. Patients with reasonable oral hygiene. 5. Partially or totally edentulous alveolar ridges. - Exclusion Criteria:

1. Uncontrolled medically compromised patients such as : (heart diseases uncontrolled blood pressure, endocrine disorders such as (diabetes , Thyroid disorders , osteoporosis ) , immuno-compromised patient and any condition influence bone healing ……etc. 2. Heavy smokers ( ≥ 20 cigarettes a day). 3. Patients with parafunctional habits. 4. Complicated cases according to SAC classification. 5. Patient with signs of acute infection and purulent exudates at the site of implant placement as revealed by clinical and radiographical examination. -

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Sora Salam Majeed
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Sora Salam Majeed, college of dentistry university of baghdad – University of Baghdad

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.